The Chemistry and Pharmaceutical sciences group at Vrije Universiteit Amsterdam (VU) has recently rejoined Innovation Lab Chemistry (ILCA), which provides innovation support to chemical companies, supported by various organisations in the region. With this participation, the VU hopes to contribute new knowledge and expertise in addition to the existing universities that are already part of the Innovation Lab.
At ILCA it is seen as good news: “We are very pleased that VU adds their Pharmaceutical chemistry knowledge to the portfolio of expertise of ILCA. This means that companies and organizations in the MRA can benefit from a broader range of services to support their innovations and operational challenges”, says Willem Fokkema, director at ILCA.
The participation of VU will be coordinated by IXA-VU. “We make sure that questions from companies arrive on the right place” adds Ties van Rappard, business developer at VU. “We have extensive pharmaceutical expertise and (analytical) infrastructure in the labs of Prof Tom Grossmann useful for Lifesciences startup companies but also for mature companies in need for specific instruments. Regardless the question; analysis or synthesis. We find solutions”.
Sem Vijverberg – PhD Candidate at Vrije Universiteit Amsterdam – and University of Amsterdam PostDoc researcher Tijmen Bakker have been selected as participants in the Faculty of Impact, and will be taking part in an intensive two year program where ten ambitious scientists work with each other and with a selection of experts to conquer […]
NewsEvery language contains riddles and secrets, currently there are seven thousand+ known languages. A treasure trove of colourful, curious and enigmatic stories. Every language tells a story about and gives a picture of the culture and the people that speak or have spoken this language. And every language is full of riddles and secrets that […]
NewsAnya Biotech, representing Amsterdam UMC, has won the second edition of the Proefdiervrij Venture Challenge on the 22nd of April 2022. Their winning innovation is based on research from the Department of Medical Biology at the AMC. The team takes home €25.000, – in prize money to kick-start their venture based on human heart models […]
News